EQL PHARMA AB (7JK) — Financial Flexibility Index
Latest as of December 2025:
0.05x
EQL PHARMA AB (7JK) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of €25.32 Million (operating CF €13.44 Million minus capex €11.87 Million) represents 0% of total liabilities (€543.76 Million).
Financial Flexibility Index
0.05x
Free Cash Flow / Total Liabilities
Free Cash Flow
€25.32 Million
Operating CF − Capex
Total Liabilities
€543.76 Million
EUR
Capital Expenditures
€11.87 Million
EUR
EQL PHARMA AB Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for EQL PHARMA AB across 4 annual periods. See working capital to net assets of EQL PHARMA AB to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for EQL PHARMA AB (2022–2025)
Year-by-year free cash flow to debt coverage for EQL PHARMA AB. For the full company profile including market capitalisation, see market cap of EQL PHARMA AB.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | €221.19 Million | €-24.65 Million | €587.79 Million | ▲ +34.6% |
| 2024 | 0.28x | €54.83 Million | €-11.44 Million | €196.03 Million | ▼ -23.9% |
| 2023 | 0.37x | €48.12 Million | €27.62 Million | €130.94 Million | ▼ -34.3% |
| 2022 | 0.56x | €63.92 Million | €41.83 Million | €114.26 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities